參考文獻
［1］Nakajima T, Nashimoto A, Kitamura M, et al. Adjuvant MMC and 5 FU followed by oral plus tegafur in serosa negative gastric cancer:a randomized trial. Lancet,1999, 354:273-277.
［2］柴田近，暇託遙摯擔赴┲委がイドテイン．外科治，2006,94:134 141.
［3］古河洋，今村博司，岸本明乃，他．他K器合闈諧蕪m應と手技．手g,2008,62:593-597.
［4］Saka M, Mudan SS, Katai H, et al. Pancreaticoduodenectomy for advanced gastric Cancer. Gastric Cancer, 2005, 8: 1-5.
［5］Saka M, Sano T, Yamamoto S, et al. D2 lymphadenectomy alone or with para aortic nodal dissection for gastric cancer. N Engl J Med, 2008, 359: 453-462.
［6］梨本V，藪崎裕，中山悟．JCOG9501の結果を踏まぇた胃癌進行胃癌の手g治．外科治,2007,95:370-381.
［7］Sobin LH, Wittekind CH. International Union Against Cancer: TNM classification of malignant tumors. 6th ed. New York: John Wiley&Sons, 2002.
［8］大橋學,神田Q夫,金子耕司,他．進行再k胃癌にする新規抗癌劑を用ぃた外來化學法．臨外,2007,62:637-646.
［9］MacDonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med, 2001, 345:725-730.
［10］MacDonald JS. Role of postoperative chemoradiation in resected gastric cancer. J Surg Oncol, 2005, 90: 166-170.
［11］Cunningham D, Allumw H, Slenning SP, et al. Perioperative chemotherapy versus surgery alone for respectable gastroesophageal cancer. N Engl J Med, 2006, 355: 11-20.
［12］MacDonald JS. Gastric cancer new therapeutic option. N Engl J Med, 2006, 355:76-77.
［13］Cunningham D, Starling N, Rao S, et al.Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med,2008,358:36-46.
［14］中u，木下平，梨本V，他．胃癌術後輔助化學療法N SAS GC trial の最終解析結果．第79回日本胃癌學會總會（54-1）論文彙編，2007.
［15］櫻本信一,菊池史郎,二渡信江,他.胃癌術後輔助化學療法．外科治療,2007,94:363-369.
［16］Tsuburaya A, Sakamoto J, Morita S, et al. A randomized phase Ⅲ trail of post-operative adjuvant oral fluoropyrimidine; and UFT vs. S1 for T3/T4 gastric carcinoma: the stomach cancer adjuvant multi institutional trail group(SAMIT) trail. Jpn J Clin Oncol,2005,35: 672-675.
［17］陳峻青,王梅先,齊春蓮,等.胃癌淋巴結轉移及其分型的病理生物學意義.中國實用外科雜誌,1989,9:478-481.
［18］陳峻青,王舒寶,徐惠綿,等.胃癌根治切除並溫熱低滲液腹腔灌洗的療效分析.中華醫學雜誌,2001,81:730-732.